NCT07727343Not yet recruiting
AI-Guided TURBT for Bladder Cancer
Evaluation of the Efficacy and Safety of an AI Navigation Planning System in Transurethral Resection of Bladder Tumor: A Prospective, Randomized, Controlled, Single-Center Study
Source: ClinicalTrials.gov · Last updated 27 Jul 2026
Brief summary (registry, in English)
This prospective, randomized, controlled, single-center study evaluates whether an AI navigation planning system used during Transurethral Resection of Bladder Tumor (TURBT) can improve recurrence-free survival in patients with non-muscle invasive bladder cancer. Participants are randomized to receive either standard TURBT surgery or standard TURBT with AI-assisted real-time tumor identification and resection margin guidance. The primary outcome is recurrence-free survival, with secondary outcomes including surgical duration, intraoperative blood loss, perioperative bleeding, and complication rates. The study aims to provide high-level evidence on the clinical utility of AI-assisted surgical navigation in bladder cancer treatment.
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 170 (estimated)
- First submitted
- 19 Jul 2026
- Start date
- Aug 2026
- Primary completion date
- May 2027
- Lead sponsor
- Fudan University
- Diseases
- Bladder cancer
- NCT number
- NCT07727343
What you commit to
- Study type: Interventional
- Planned participants: 170
- From Aug 2026 to the primary completion date, May 2027
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Severe dysfunction of other vital organs (heart, lungs, kidneys, etc.).
- Severe infection or active inflammation.
- Psychiatric disorders or inability to comply with study procedures.
- Any other condition deemed by the investigator as inappropriate for participation.
Other
- Pregnant or lactating women.
- Imaging evidence of distant metastases.
Who the study is looking for
- Age between 18 and 75 years, male or female.
- Clinical or imaging diagnosis of non-muscle invasive bladder cancer (NMIBC) according to international diagnostic standards (CT, MRI, ultrasound, cystoscopy).
- Medically fit for TURBT surgery, with normal or essentially normal renal, cardiopulmonary, and hepatic function.
- Willing and able to provide written informed consent (signed by the patient or a legally authorized representative).
Age in the registry: 18 years to 75 years · Sex: All · Does not accept healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.